Logo image of BRZE

BRAZE INC-A (BRZE) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:BRZE - US10576N1028 - Common Stock

23.03 USD
-2.45 (-9.62%)
Last: 1/16/2026, 8:00:02 PM
23.1595 USD
+0.13 (+0.56%)
After Hours: 1/16/2026, 8:00:02 PM
Fundamental Rating

4

BRZE gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 277 industry peers in the Software industry. The financial health of BRZE is average, but there are quite some concerns on its profitability. BRZE is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year BRZE was profitable.
  • In the past year BRZE had a positive cash flow from operations.
  • BRZE had negative earnings in each of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: BRZE reported negative operating cash flow in multiple years.
BRZE Yearly Net Income VS EBIT VS OCF VS FCFBRZE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 -50M -100M

1.2 Ratios

  • BRZE's Return On Assets of -11.22% is on the low side compared to the rest of the industry. BRZE is outperformed by 64.62% of its industry peers.
  • BRZE's Return On Equity of -19.41% is on the low side compared to the rest of the industry. BRZE is outperformed by 60.29% of its industry peers.
Industry RankSector Rank
ROA -11.22%
ROE -19.41%
ROIC N/A
ROA(3y)-15.85%
ROA(5y)-15.52%
ROE(3y)-27.38%
ROE(5y)-29.17%
ROIC(3y)N/A
ROIC(5y)N/A
BRZE Yearly ROA, ROE, ROICBRZE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 -10 -20 -30 -40

1.3 Margins

  • With a Gross Margin value of 68.13%, BRZE perfoms like the industry average, outperforming 48.38% of the companies in the same industry.
  • BRZE's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for BRZE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 68.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.04%
GM growth 5Y1.88%
BRZE Yearly Profit, Operating, Gross MarginsBRZE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60

6

2. Health

2.1 Basic Checks

  • BRZE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, BRZE has more shares outstanding
  • The number of shares outstanding for BRZE has been increased compared to 5 years ago.
  • BRZE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BRZE Yearly Shares OutstandingBRZE Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
BRZE Yearly Total Debt VS Total AssetsBRZE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • An Altman-Z score of 3.00 indicates that BRZE is not in any danger for bankruptcy at the moment.
  • BRZE's Altman-Z score of 3.00 is fine compared to the rest of the industry. BRZE outperforms 60.29% of its industry peers.
  • There is no outstanding debt for BRZE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3
ROIC/WACCN/A
WACC11.12%
BRZE Yearly LT Debt VS Equity VS FCFBRZE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M 500M

2.3 Liquidity

  • A Current Ratio of 1.36 indicates that BRZE should not have too much problems paying its short term obligations.
  • BRZE has a Current ratio (1.36) which is comparable to the rest of the industry.
  • BRZE has a Quick Ratio of 1.36. This is a normal value and indicates that BRZE is financially healthy and should not expect problems in meeting its short term obligations.
  • BRZE has a Quick ratio of 1.36. This is comparable to the rest of the industry: BRZE outperforms 42.24% of its industry peers.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 1.36
BRZE Yearly Current Assets VS Current LiabilitesBRZE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 200M 400M 600M

7

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 1900.00% over the past year.
  • The Revenue has grown by 22.95% in the past year. This is a very strong growth!
  • BRZE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 43.83% yearly.
EPS 1Y (TTM)1900%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
Revenue 1Y (TTM)22.95%
Revenue growth 3Y35.6%
Revenue growth 5Y43.83%
Sales Q2Q%25.51%

3.2 Future

  • Based on estimates for the next years, BRZE will show a very strong growth in Earnings Per Share. The EPS will grow by 59.65% on average per year.
  • Based on estimates for the next years, BRZE will show a quite strong growth in Revenue. The Revenue will grow by 18.26% on average per year.
EPS Next Y138.89%
EPS Next 2Y89.51%
EPS Next 3Y77.23%
EPS Next 5Y59.65%
Revenue Next Year24.2%
Revenue Next 2Y20.71%
Revenue Next 3Y19.31%
Revenue Next 5Y18.26%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
BRZE Yearly Revenue VS EstimatesBRZE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
BRZE Yearly EPS VS EstimatesBRZE Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 1.5

4

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 57.58, BRZE can be considered very expensive at the moment.
  • BRZE's Price/Earnings is on the same level as the industry average.
  • The average S&P500 Price/Earnings ratio is at 27.38. BRZE is valued rather expensively when compared to this.
  • BRZE is valuated quite expensively with a Price/Forward Earnings ratio of 35.62.
  • BRZE's Price/Forward Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.29, BRZE is valued a bit more expensive.
Industry RankSector Rank
PE 57.58
Fwd PE 35.62
BRZE Price Earnings VS Forward Price EarningsBRZE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • 60.29% of the companies in the same industry are more expensive than BRZE, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 43.15
EV/EBITDA N/A
BRZE Per share dataBRZE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • BRZE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as BRZE's earnings are expected to grow with 77.23% in the coming years.
PEG (NY)0.41
PEG (5Y)N/A
EPS Next 2Y89.51%
EPS Next 3Y77.23%

0

5. Dividend

5.1 Amount

  • No dividends for BRZE!.
Industry RankSector Rank
Dividend Yield 0%

BRAZE INC-A

NASDAQ:BRZE (1/16/2026, 8:00:02 PM)

After market: 23.1595 +0.13 (+0.56%)

23.03

-2.45 (-9.62%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)12-09
Earnings (Next)03-25
Inst Owners75.29%
Inst Owner Change0.4%
Ins Owners9.2%
Ins Owner Change4.17%
Market Cap2.56B
Revenue(TTM)693.41M
Net Income(TTM)-116.88M
Analysts85.19
Price Target47.63 (106.82%)
Short Float %6.25%
Short Ratio2.92
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)192.95%
Min EPS beat(2)-5.12%
Max EPS beat(2)391.01%
EPS beat(4)3
Avg EPS beat(4)140.47%
Min EPS beat(4)-5.12%
Max EPS beat(4)391.01%
EPS beat(8)7
Avg EPS beat(8)191.16%
EPS beat(12)11
Avg EPS beat(12)143.38%
EPS beat(16)15
Avg EPS beat(16)112.23%
Revenue beat(2)2
Avg Revenue beat(2)2.72%
Min Revenue beat(2)1.64%
Max Revenue beat(2)3.8%
Revenue beat(4)4
Avg Revenue beat(4)1.64%
Min Revenue beat(4)0.14%
Max Revenue beat(4)3.8%
Revenue beat(8)8
Avg Revenue beat(8)1.47%
Revenue beat(12)12
Avg Revenue beat(12)1.76%
Revenue beat(16)16
Avg Revenue beat(16)2.28%
PT rev (1m)4.16%
PT rev (3m)3.51%
EPS NQ rev (1m)0.89%
EPS NQ rev (3m)8.79%
EPS NY rev (1m)2.46%
EPS NY rev (3m)2.29%
Revenue NQ rev (1m)0.27%
Revenue NQ rev (3m)2.95%
Revenue NY rev (1m)1.88%
Revenue NY rev (3m)1.89%
Valuation
Industry RankSector Rank
PE 57.58
Fwd PE 35.62
P/S 3.7
P/FCF 43.15
P/OCF 37.06
P/B 4.26
P/tB 9.47
EV/EBITDA N/A
EPS(TTM)0.4
EY1.74%
EPS(NY)0.65
Fwd EY2.81%
FCF(TTM)0.53
FCFY2.32%
OCF(TTM)0.62
OCFY2.7%
SpS6.23
BVpS5.41
TBVpS2.43
PEG (NY)0.41
PEG (5Y)N/A
Graham Number6.98
Profitability
Industry RankSector Rank
ROA -11.22%
ROE -19.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 68.13%
FCFM 8.56%
ROA(3y)-15.85%
ROA(5y)-15.52%
ROE(3y)-27.38%
ROE(5y)-29.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.04%
GM growth 5Y1.88%
F-Score4
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 60.58%
Cap/Sales 1.41%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.36
Quick Ratio 1.36
Altman-Z 3
F-Score4
WACC11.12%
ROIC/WACCN/A
Cap/Depr(3y)240.58%
Cap/Depr(5y)230.69%
Cap/Sales(3y)3.47%
Cap/Sales(5y)3.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1900%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
EPS Next Y138.89%
EPS Next 2Y89.51%
EPS Next 3Y77.23%
EPS Next 5Y59.65%
Revenue 1Y (TTM)22.95%
Revenue growth 3Y35.6%
Revenue growth 5Y43.83%
Sales Q2Q%25.51%
Revenue Next Year24.2%
Revenue Next 2Y20.71%
Revenue Next 3Y19.31%
Revenue Next 5Y18.26%
EBIT growth 1Y4.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year797.47%
EBIT Next 3Y189.8%
EBIT Next 5Y124.87%
FCF growth 1Y1317.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2175.29%
OCF growth 3YN/A
OCF growth 5YN/A

BRAZE INC-A / BRZE FAQ

Can you provide the ChartMill fundamental rating for BRAZE INC-A?

ChartMill assigns a fundamental rating of 4 / 10 to BRZE.


Can you provide the valuation status for BRAZE INC-A?

ChartMill assigns a valuation rating of 4 / 10 to BRAZE INC-A (BRZE). This can be considered as Fairly Valued.


How profitable is BRAZE INC-A (BRZE) stock?

BRAZE INC-A (BRZE) has a profitability rating of 2 / 10.


What is the earnings growth outlook for BRAZE INC-A?

The Earnings per Share (EPS) of BRAZE INC-A (BRZE) is expected to grow by 138.89% in the next year.